NEW ORLEANS – In vitro data translated well to in vivo findings in MRSA treatment.
SAN FRANCISCO – Effective antibiotics may not be available to treat seriously ill patients in the near future.
Twenty percent of hospitalized adults given antibiotics develop adverse drug events, including GI, nephrotoxic, hematologic, cardiac, and...
Read the latest research from the Journal of Hospital Medicine, the premier publication for dissemination of research and education for the...
Why are patients with bacterial infections being overtreated and what do we do about it?
We have created this meeting for you, and we hope it is your most valuable educational and networking opportunity of 2017.
WHO is urging governments to focus antibiotic research efforts on a list of urgent bacterial threats, topped by several increasingly powerful...
Sneak Peak: The Hospital Leader Blog “The Impact of Hospital Design on Health – for Patients AND Providers”
We owe it to ourselves to do what we can to improve our work settings.
Use of the procalcitonin assay has been shown to reduce antibiotic utilization without an increase in adverse outcomes.
Study shows treatment failure of complicated pneumonia is uncommon, occurs at same rate for both oral and PICC treatment.